Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study)

Published:2017-06-08 Issue:4 Volume:120 Page:562-575
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Herschorn Sender¹^ORCID,Chapple Christopher R.²,Abrams Paul³,Arlandis Salvador⁴,Mitcheson David⁵,Lee Kyu-Sung⁶,Ridder Arwin⁷,Stoelzel Matthias⁷,Paireddy Asha⁷,van Maanen Rob⁷,Robinson Dudley⁸

Affiliation:

1. Department of Surgery/Urology; University of Toronto; Sunnybrook Health Sciences Centre; Toronto ON Canada

2. Department of Urology; Royal Hallamshire Hospital; Sheffield UK

3. Bristol Urological Institute; Southmead Hospital; Bristol UK

4. Hospital Universitario La Fé; Valencia Spain

5. St. Elizabeth's Medical Center; Brighton MA USA

6. Samsung Medical Center; Sungkyunkwan University School of Medicine; Seoul Korea

7. Astellas Pharma Global Development; Leiden The Netherlands

8. Kings College Hospital; London UK

Funder

Astellas Pharma Europe B.V. Medical

Astellas Pharma Global Development, Inc

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13882/fullpdf

Reference21 articles.

1. Do we need a new definition of the overactive bladder syndrome. ICI-RS 2013;Drake;Neurourol Urodyn,2014

2. Defining overactive bladder: epidemiology and burden of disease;Tubaro;Urology,2004

3. Impact on quality of life of urinary incontinence and overactive bladder: a systematic literature review;Bartoli;Urology,2010

4. Impact of urinary incontinence and overactive bladder on quality of life;Chiaffarino;Eur Urol,2003

5. Comorbidities and personal burden of urgency urinary incontinence: a systematic review;Coyne;Int J Clin Pract,2013

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 Revised Dutch guidelines for urinary incontinence: Addressing clinical bottlenecks through a modular approach;Continence;2024-12

2. Mirabegron 50 mg once daily, long-term treatment maximizes benefit in middle-aged and older people with overactive bladder syndrome: a systematic review and meta-analysis of nine phase II/III, randomized, double-blind, parallel-design, placebo-controlled, multicenter, and multinational trials;Frontiers in Surgery;2024-08-26

3. Management of overactive bladder: consensus statements from the Hong Kong Urological Association and the Hong Kong Geriatrics Society;Hong Kong Medical Journal;2024-08-14

4. Anticholinergic adverse events by polypharmacy and anticholinergic burden score;Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics;2024-07-25

5. The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder;Neurourology and Urodynamics;2024-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3